VCEL

$0.00

(

0.00%

)
Quote details

stock

Vericel Corp Ord

NASDAQ | VCEL

39.43

USD

$0.00

(

0.00%

)

At Close (As of Nov 17, 2025)

$2.02B

Market Cap

153.31

P/E Ratio

0.26

EPS

$63.00

52 Week High

$29.24

52 Week Low

HEALTHCARE

Sector

VCEL Chart

Recent Chart
Price Action

VCEL Technicals

Tags:

VCEL Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $172M
Total Revenue $237M
Cost Of Revenue $65M
Costof Goods And Services Sold $65M
Operating Income $4.5M
Selling General And Administrative $143M
Research And Development $25M
Operating Expenses $168M
Investment Income Net -
Net Interest Income $5.8M
Interest Income $6.4M
Interest Expense $614K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.5M
Income Before Tax $11M
Income Tax Expense $148K
Interest And Debt Expense -
Net Income From Continuing Operations $10M
Comprehensive Income Net Of Tax -
Ebit $11M
Ebitda $17M
Net Income $10M

Revenue & Profitability

Earnings Performance

VCEL Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $433M
Total Current Assets $213M
Cash And Cash Equivalents At Carrying Value $75M
Cash And Short Term Investments $75M
Inventory $17M
Current Net Receivables $61M
Total Non Current Assets $220M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $6.3M
Intangible Assets Excluding Goodwill $6.3M
Goodwill -
Investments -
Long Term Investments $40M
Short Term Investments $42M
Other Current Assets $18M
Other Non Current Assets -
Total Liabilities $141M
Total Current Liabilities $50M
Current Accounts Payable $24M
Deferred Revenue -
Current Debt -
Short Term Debt $9.3M
Total Non Current Liabilities $90M
Capital Lease Obligations $99M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $99M
Other Current Liabilities $17M
Other Non Current Liabilities $876K
Total Shareholder Equity $292M
Treasury Stock -
Retained Earnings -$393M
Common Stock $685M
Common Stock Shares Outstanding $52M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $58M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $5.5M
Capital Expenditures $64M
Change In Receivables -
Change In Inventory -$4.3M
Profit Loss -
Cashflow From Investment -$79M
Cashflow From Financing $19M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $10M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $172M
Total Revenue $237M
Cost Of Revenue $65M
Costof Goods And Services Sold $65M
Operating Income $4.5M
Selling General And Administrative $143M
Research And Development $25M
Operating Expenses $168M
Investment Income Net -
Net Interest Income $5.8M
Interest Income $6.4M
Interest Expense $614K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.5M
Income Before Tax $11M
Income Tax Expense $148K
Interest And Debt Expense -
Net Income From Continuing Operations $10M
Comprehensive Income Net Of Tax -
Ebit $11M
Ebitda $17M
Net Income $10M

VCEL News

VCEL Profile

Vericel Corp Ord Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Vericel Corporation (VCEL) is a pioneering commercial-stage biopharmaceutical company based in Cambridge, Massachusetts, specializing in advanced cell therapies for sports medicine and severe burn care. The company's proprietary products, including MACI® and Epicel®, exemplify its commitment to enhancing patient outcomes through innovative solutions. With a strong focus on research and development, Vericel is dedicated to addressing unmet medical needs in the field of regenerative medicine, positioning itself as a leader in niche therapeutic markets. As it continues to expand its product offerings and technological capabilities, Vericel remains well-poised to drive significant advancements in patient care.

WTO
+25.52%
$0.03
LPTX
+368.57%
$2.05
APLT
+30.18%
$0.28
AMIX
+58.18%
$1.15
NVDA
-1.87%
$186.60
ONDS
-12.88%
$6.25
CHR
-2.66%
$0.04
ASST
-3.70%
$1.04
TSLA
+1.13%
$408.92
GLMD
+0.96%
$1.05
PFE
+0.07%
$25.08
SOFI
-2.80%
$27.04
F
-2.35%
$12.88
PLUG
-7.12%
$2.08
DVLT
+1.91%
$1.86
INTC
-2.28%
$34.71
QUBT
+8.49%
$11.50
GNS
-9.87%
$0.77
ACHR
-5.83%
$7.42
VHAI
-25.00%
$0.00
AXDX
-61.36%
$0.03
DNN
-3.62%
$2.39
BYND
-3.70%
$1.04
AMZN
-0.77%
$232.87
BITF
+3.48%
$2.67
RIVN
-1.58%
$14.87
BMNR
-10.02%
$30.95
ETHD
+8.79%
$5.69
DFLI
-1.27%
$0.80
KVUE
-2.61%
$16.22
MARA
-4.00%
$11.51
NIO
-1.29%
$6.08
GOOGL
+3.11%
$285.02
ADAP
-15.14%
$0.05
SNAP
-4.55%
$8.18
PLTR
-1.58%
$171.25
HPE
-7.00%
$21.23
RIG
+1.74%
$4.08
TLRY
-4.62%
$1.03
BURU
-13.34%
$0.21
AAPL
-1.81%
$267.46
CIFR
-0.06%
$14.35
AAL
-3.29%
$12.34
RGTI
-3.10%
$24.69
GRAB
-1.47%
$5.33
WULF
+0.54%
$11.05
ASBP
-14.11%
$0.09
RMBL
+60.50%
$3.21
HOOD
-5.33%
$115.97
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
MSPR
+18.40%
$0.53
AMD
-2.54%
$240.52
WBD
-1.25%
$22.74
BAC
-2.14%
$51.48
BTG
-2.68%
$3.99
CAN
-4.37%
$0.85
XPEV
-10.31%
$22.43
SRM
+53.27%
$10.30
T
-0.46%
$25.47
GOOG
+3.11%
$285.60
NOK
-0.89%
$6.67
IREN
+2.24%
$47.41
SMCI
-6.37%
$34.10
GPUS
-7.60%
$0.27
BBD
-1.63%
$3.62
AMC
-4.82%
$2.17
HIMS
-3.78%
$35.58
PLTD
-1.01%
$6.84
BTBT
-4.56%
$2.30
MU
-1.97%
$241.95
QBTS
-3.30%
$22.83
OWL
-5.81%
$13.77
HBAN
-2.73%
$15.30
BTE
-4.43%
$3.02
SOUN
-6.08%
$11.43
CRWV
-2.62%
$75.33
WLGS
-5.57%
$0.04
CSCO
-0.28%
$77.78
IONZ
-3.07%
$5.04
CLSK
-3.19%
$10.61
VALE
-1.05%
$12.17
MTSR
-0.35%
$70.50
NFLX
-0.83%
$110.29
ABEV
-0.39%
$2.54
APLD
-3.02%
$22.93
EOSE
-5.79%
$13.00
RXRX
-0.48%
$4.12
SMR
-6.19%
$21.06
CLF
+2.23%
$10.97
TWOH
0.00%
$0.00
CRCL
-6.47%
$76.59
AFMD
-34.94%
$0.18
IVVD
+20.85%
$2.84
NBIS
+2.92%
$85.98
QS
-3.57%
$12.95
AMCR
-0.29%
$8.45
KDP
-0.62%
$26.96
JOBY
-3.60%
$13.89
RIOT
-0.50%
$13.88
WTO
+25.52%
$0.03
LPTX
+368.57%
$2.05
APLT
+30.18%
$0.28
AMIX
+58.18%
$1.15
NVDA
-1.87%
$186.60
ONDS
-12.88%
$6.25
CHR
-2.66%
$0.04
ASST
-3.70%
$1.04
TSLA
+1.13%
$408.92
GLMD
+0.96%
$1.05
PFE
+0.07%
$25.08
SOFI
-2.80%
$27.04
F
-2.35%
$12.88
PLUG
-7.12%
$2.08
DVLT
+1.91%
$1.86
INTC
-2.28%
$34.71
QUBT
+8.49%
$11.50
GNS
-9.87%
$0.77
ACHR
-5.83%
$7.42
VHAI
-25.00%
$0.00
AXDX
-61.36%
$0.03
DNN
-3.62%
$2.39
BYND
-3.70%
$1.04
AMZN
-0.77%
$232.87
BITF
+3.48%
$2.67
RIVN
-1.58%
$14.87
BMNR
-10.02%
$30.95
ETHD
+8.79%
$5.69
DFLI
-1.27%
$0.80
KVUE
-2.61%
$16.22
MARA
-4.00%
$11.51
NIO
-1.29%
$6.08
GOOGL
+3.11%
$285.02
ADAP
-15.14%
$0.05
SNAP
-4.55%
$8.18
PLTR
-1.58%
$171.25
HPE
-7.00%
$21.23
RIG
+1.74%
$4.08
TLRY
-4.62%
$1.03
BURU
-13.34%
$0.21
AAPL
-1.81%
$267.46
CIFR
-0.06%
$14.35
AAL
-3.29%
$12.34
RGTI
-3.10%
$24.69
GRAB
-1.47%
$5.33
WULF
+0.54%
$11.05
ASBP
-14.11%
$0.09
RMBL
+60.50%
$3.21
HOOD
-5.33%
$115.97
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
MSPR
+18.40%
$0.53
AMD
-2.54%
$240.52
WBD
-1.25%
$22.74
BAC
-2.14%
$51.48
BTG
-2.68%
$3.99
CAN
-4.37%
$0.85
XPEV
-10.31%
$22.43
SRM
+53.27%
$10.30
T
-0.46%
$25.47
GOOG
+3.11%
$285.60
NOK
-0.89%
$6.67
IREN
+2.24%
$47.41
SMCI
-6.37%
$34.10
GPUS
-7.60%
$0.27
BBD
-1.63%
$3.62
AMC
-4.82%
$2.17
HIMS
-3.78%
$35.58
PLTD
-1.01%
$6.84
BTBT
-4.56%
$2.30
MU
-1.97%
$241.95
QBTS
-3.30%
$22.83
OWL
-5.81%
$13.77
HBAN
-2.73%
$15.30
BTE
-4.43%
$3.02
SOUN
-6.08%
$11.43
CRWV
-2.62%
$75.33
WLGS
-5.57%
$0.04
CSCO
-0.28%
$77.78
IONZ
-3.07%
$5.04
CLSK
-3.19%
$10.61
VALE
-1.05%
$12.17
MTSR
-0.35%
$70.50
NFLX
-0.83%
$110.29
ABEV
-0.39%
$2.54
APLD
-3.02%
$22.93
EOSE
-5.79%
$13.00
RXRX
-0.48%
$4.12
SMR
-6.19%
$21.06
CLF
+2.23%
$10.97
TWOH
0.00%
$0.00
CRCL
-6.47%
$76.59
AFMD
-34.94%
$0.18
IVVD
+20.85%
$2.84
NBIS
+2.92%
$85.98
QS
-3.57%
$12.95
AMCR
-0.29%
$8.45
KDP
-0.62%
$26.96
JOBY
-3.60%
$13.89
RIOT
-0.50%
$13.88

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.